Cellectar Biosciences, Inc.

NASDAQ:CLRB

0.2515 (USD) • At close May 8, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

202420232022202120202019201820172016201520142013201220112010200920082007200620052004
Assets:
Current Assets:
Cash & Cash Equivalents 23.2899.56519.86635.70457.16510.61513.25610.00611.4453.8589.4232.4184.6785.5062.3738.771.2629.7429.9384.2670.01
Short Term Investments 0000000.0550.0550.0550.05500000000000
Cash and Short Term Investments 23.2899.56519.86635.70457.16510.61513.25610.00611.4453.8589.4232.4184.6785.5062.3738.771.2629.7429.9384.2670.01
Net Receivables 000000000000000000000.013
Inventory 000000000000000000000
Other Current Assets 0.9620.8880.6631.7351.5491.5420.6961.3450.7490.3230.2760.350.4530.310.1150.2060.261.3181.950.5350.08
Total Current Assets 24.2510.45320.5336.57157.9411.38613.95210.93912.1934.1819.6982.7685.135.8162.4368.8721.39211.0611.8894.8020.103
Non-Current Assets:
Property, Plant & Equipment, Net 1.1941.5930.9790.5490.6380.7840.5430.2451.4441.7282.0342.3612.6453.0450.0090.0440.0580.0330.0240.0230
Goodwill 00000001.6751.6751.6751.6751.6751.6751.6750000000
Intangible Assets 00000001.6751.6751.67500000000000
Goodwill and Intangible Assets 00000001.6751.6751.6751.6751.6751.6751.6750000000
Long Term Investments 000000000000000.0150.01500000
Tax Assets 000000000000000000000
Other Non-Current Assets 0.030.030.0810.0810.0810.0810.5590.0120.0120.0120.0120.0122.0270.027000.0150.0150.0110.1140.006
Total Non-Current Assets 1.2241.6221.060.630.720.8651.1021.9323.1313.4163.7214.0486.3484.7470.0240.0590.0740.0480.0350.1370.006
Total Assets 25.47412.07621.5937.20258.65912.25115.05412.87115.3257.59613.426.81611.47810.5632.4618.9321.46611.10811.9234.9390.109
Liabilities & Equity:
Current Liabilities:
Account Payables 0.6115.622.5581.4151.4291.2780.6120.9331.4160.0010.0010.0010.7170.4780.3933.2994.6546.3721.0880.2112.026
Short Term Debt 0.0840.0590.1020.2710.120.2120.0040.0060.0920.2480.1240.0030.0050.0040.002000002.02
Tax Payables 000000000000000000000
Deferred Revenue 0002.442.0141.3860.965-1.868-1.416-0.001-0.001-0.001000.0330.0330.0330000
Other Current Liabilities 8.69219.682.872.3042.0141.281.0061.1760.1245.4542.064.5190.0110.0210.45913.6351.930.6870.2250.0060.398
Total Current Liabilities 9.38825.3595.5293.993.5632.771.6222.1151.6335.7032.1854.5230.7330.5040.88716.9686.6177.0591.3130.2174.444
Non-Current Liabilities:
Long Term Debt 00.4940.5530.1660.3020.42200.0020.0050.0950.3410.450.4520.4540.006000000
Deferred Revenue Non-Current 00000000000000.1240.3670.40.4330000.013
Deferred Tax Liabilities Non-Current 0000000000000-0.1240000000
Other Non-Current Liabilities 1.792000000.17100.1470.1490.1480.1430.1350-0.00618.4609.919000.001
Total Non-Current Liabilities 1.7920.4940.5530.1660.3020.4220.1710.0020.1520.2440.4890.5930.5870.5780.36718.860.4339.919000.014
Total Liabilities 11.17925.8536.0824.1573.8653.1911.7932.1171.7855.9472.6745.1161.321.0821.25435.8277.05116.9781.3130.2174.458
Equity:
Preferred Stock 0.5216.061.3821.38220.0361.1482.5260.9960.876000002.46118.4613.9049.919000
Common Stock 0000.00100000000.001000.0050.00100000
Retained Earnings -247.342-217.483-179.499-150.898-126.775-111.681-97.588-84.349-70.787-64.607-59.166-51.06-40.277-31.48-73.977-76.072-59.693-43.242-23.685-15.399-12.345
Accumulated Other Comprehensive Income/Loss 0000000000-0-000-2.461-18.460-9.919000
Other Total Stockholders Equity 261.116196.264193.624182.56161.534119.592108.32394.10883.46266.25669.91252.75950.43540.96172.71886.09540.20447.2934.29420.127.996
Total Shareholders Equity 14.295-15.15915.50833.04554.7959.05913.26110.75413.541.6510.7461.710.1589.4811.207-26.896-5.585-5.8710.614.722-4.349
Total Equity 14.295-15.15915.50833.04554.7959.05913.26110.75413.541.6510.7461.710.1589.4811.207-26.896-5.585-5.8710.614.722-4.349
Total Liabilities & Shareholders Equity 25.47412.07621.5937.20258.65912.25115.05412.87115.3257.59613.426.81611.47810.5632.4618.9321.46611.10811.9234.9390.109